Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Kneebone

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 2024
Utility of <sup>64</sup>Cu-Sarcophagine-Bombesin PET/CT in Men with Biochemically Recurrent Prostate Cancer and Negative or Equivocal Findings on <sup>68</sup>Ga-PSMA-11 PET/CTSherrington Li, Andrew Nguyen, William Counter, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 2024
Real-World Implementation of Simulation-Free Radiation Therapy (SFRT-1000): A Propensity Score-Matched Analysis of 1000 Consecutive Palliative Courses Delivered in Routine CareThilo Schuler, Stephanie Roderick, Shelley Wong, et al.
Practical Radiation Oncology|November 26, 2019
Australasian Gastrointestinal Trials Group (AGITG) and Trans-Tasman Radiation Oncology Group (TROG) Guidelines for Pancreatic Stereotactic Body Radiation Therapy (SBRT)Andrew Oar, Mark Lee, Hien Le, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 24, 2020
Is multileaf collimator tracking or gating a better intrafraction motion adaptation strategy? An analysis of the TROG 15.01 stereotactic prostate ablative radiotherapy with KIM (SPARK) trialEmily A Hewson, Doan T Nguyen, Ricky O'Brien, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 3, 2019
3-Year Freedom from Progression After <sup>68</sup>Ga-PSMA PET/CT-Triaged Management in Men with Biochemical Recurrence After Radical Prostatectomy: Results of a Prospective Multicenter TrialLouise Emmett, Reuben Tang, Rohan Nandurkar, et al.
BJU International|June 5, 2014
A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy -- Adjuvant Versus Early Salvage (RAVES) trialMaria Pearse, Carol Fraser-Browne, Ian D Davis, et al.
Medical Physics|August 26, 2019
The accuracy and precision of the KIM motion monitoring system used in the multi-institutional TROG 15.01 Stereotactic Prostate Ablative Radiotherapy with KIM (SPARK) trialEmily A Hewson, Doan Trang Nguyen, Ricky O'Brien, et al.
European Urology|March 28, 2026
Prospective Comparison of <sup>64</sup>Copper [<sup>64</sup>Cu]SAR-bisPSMA vs <sup>68</sup>Gallium[<sup>68</sup>Ga] PSMA-11 PET/CT for Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy (Co-PSMA Trial)Sobia Khan, Nathan Papa, Andrew Kneebone, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|October 15, 2018
Monitoring quality of care for patients with pancreatic cancer: a modified Delphi consensusAshika D Maharaj, Liane Ioannou, Daniel Croagh, et al.
European Urology Oncology|July 9, 2026
Quality of Life After Postprostatectomy Radiotherapy: A TROG 08.03 RAVES Randomized Controlled Trial SubstudyJustin Smith, Gill M Duchesne, Andrew Kneebone, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 2024
Utility of <sup>64</sup>Cu-Sarcophagine-Bombesin PET/CT in Men with Biochemically Recurrent Prostate Cancer and Negative or Equivocal Findings on <sup>68</sup>Ga-PSMA-11 PET/CTSherrington Li, Andrew Nguyen, William Counter, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 2024
Real-World Implementation of Simulation-Free Radiation Therapy (SFRT-1000): A Propensity Score-Matched Analysis of 1000 Consecutive Palliative Courses Delivered in Routine CareThilo Schuler, Stephanie Roderick, Shelley Wong, et al.
Practical Radiation Oncology|November 26, 2019
Australasian Gastrointestinal Trials Group (AGITG) and Trans-Tasman Radiation Oncology Group (TROG) Guidelines for Pancreatic Stereotactic Body Radiation Therapy (SBRT)Andrew Oar, Mark Lee, Hien Le, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 24, 2020
Is multileaf collimator tracking or gating a better intrafraction motion adaptation strategy? An analysis of the TROG 15.01 stereotactic prostate ablative radiotherapy with KIM (SPARK) trialEmily A Hewson, Doan T Nguyen, Ricky O'Brien, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 3, 2019
3-Year Freedom from Progression After <sup>68</sup>Ga-PSMA PET/CT-Triaged Management in Men with Biochemical Recurrence After Radical Prostatectomy: Results of a Prospective Multicenter TrialLouise Emmett, Reuben Tang, Rohan Nandurkar, et al.
BJU International|June 5, 2014
A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy -- Adjuvant Versus Early Salvage (RAVES) trialMaria Pearse, Carol Fraser-Browne, Ian D Davis, et al.
Medical Physics|August 26, 2019
The accuracy and precision of the KIM motion monitoring system used in the multi-institutional TROG 15.01 Stereotactic Prostate Ablative Radiotherapy with KIM (SPARK) trialEmily A Hewson, Doan Trang Nguyen, Ricky O'Brien, et al.
European Urology|March 28, 2026
Prospective Comparison of <sup>64</sup>Copper [<sup>64</sup>Cu]SAR-bisPSMA vs <sup>68</sup>Gallium[<sup>68</sup>Ga] PSMA-11 PET/CT for Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy (Co-PSMA Trial)Sobia Khan, Nathan Papa, Andrew Kneebone, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|October 15, 2018
Monitoring quality of care for patients with pancreatic cancer: a modified Delphi consensusAshika D Maharaj, Liane Ioannou, Daniel Croagh, et al.
European Urology Oncology|July 9, 2026
Quality of Life After Postprostatectomy Radiotherapy: A TROG 08.03 RAVES Randomized Controlled Trial SubstudyJustin Smith, Gill M Duchesne, Andrew Kneebone, et al.
Pageof 13